Free Trial

Arbutus Biopharma (ABUS) Institutional Ownership

Arbutus Biopharma logo
$4.33 +0.24 (+5.87%)
Closing price 09/9/2025 04:00 PM Eastern
Extended Trading
$4.40 +0.07 (+1.62%)
As of 07:04 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Arbutus Biopharma (NASDAQ:ABUS)

Current
Institutional Ownership
Percentage
43.79%
Number of
Institutional Buyers
(last 12 months)
80
Total
Institutional Inflows
(last 12 months)
$69.21M
Number of
Institutional Sellers
(last 12 months)
37
Total
Institutional Outflows
(last 12 months)
$16.52M
Get ABUS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Arbutus Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

ABUS Institutional Buying and Selling by Quarter

Arbutus Biopharma Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
9/4/2025Osaic Holdings Inc.1,338,516$4.14M0.0%-0.5%0.698%
8/18/2025Hudson Bay Capital Management LP965,000$2.98M0.0%-22.5%0.503%
8/15/2025Tower Research Capital LLC TRC 20,760$64K0.0%+220.1%0.011%
8/15/2025Exome Asset Management LLC75,484$233K0.1%N/A0.039%
8/15/2025Rafferty Asset Management LLC88,454$273K0.0%+6.7%0.046%
8/15/2025Rangeley Capital LLC865,000$2.67M3.3%-35.9%0.451%
8/15/2025Rubric Capital Management LP1,575,376$4.87M0.1%-6.3%0.822%
8/15/2025Oxford Asset Management LLP12,143$38K0.0%N/A0.006%
8/15/2025Man Group plc38,997$121K0.0%N/A0.020%
8/15/2025Hudson Bay Capital Management LP965,000$2.98M0.0%-22.5%0.503%
8/15/2025BNP Paribas Financial Markets55,951$173K0.0%-69.5%0.029%
8/15/2025Boothbay Fund Management LLC262,277$810K0.0%+61.6%0.137%
8/15/2025BlackBarn Capital Partners LP2,603,521$8.05M0.5%+11.2%1.358%
8/15/2025Bank of America Corp DE1,197,655$3.70M0.0%+161.4%0.625%
8/15/2025Adage Capital Partners GP L.L.C.2,575,941$7.96M0.0%+63.5%1.344%
8/15/2025Ameriprise Financial Inc.11,440$35K0.0%-39.2%0.006%
8/14/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.87,349$270K0.0%-4.2%0.046%
8/14/2025Caption Management LLC41,866$129K0.0%+73.0%0.022%
8/14/2025The Manufacturers Life Insurance Company 59,350$183K0.0%+6.3%0.031%
8/14/2025Qube Research & Technologies Ltd368,030$1.14M0.0%+24.6%0.192%
8/14/2025Daiwa Securities Group Inc.15,844$49K0.0%+3,911.1%0.008%
8/13/2025Two Seas Capital LP10,443,317$32.27M0.5%+10.3%5.448%
8/13/2025Kennedy Capital Management LLC449,179$1.39M0.0%+7.1%0.234%
8/13/2025Invesco Ltd.181,084$560K0.0%+29.8%0.094%
8/13/2025Schroder Investment Management Group121,313$375K0.0%N/A0.063%
8/13/2025Virtus Investment Advisers LLC26,266$81K0.0%-43.0%0.014%
8/12/2025XTX Topco Ltd23,914$74K0.0%-67.0%0.012%
8/12/2025Prudential Financial Inc.18,255$56K0.0%+71.5%0.010%
8/12/2025Rhumbline Advisers207,805$642K0.0%+3.5%0.108%
8/12/2025Franklin Resources Inc.104,423$323K0.0%+13.0%0.054%
8/12/2025Legal & General Group Plc124,486$385K0.0%+5.1%0.065%
8/12/2025JPMorgan Chase & Co.86,077$266K0.0%-84.0%0.045%
8/12/2025Ensign Peak Advisors Inc45,000$139K0.0%+105.9%0.023%
8/8/2025Creative Planning52,938$164K0.0%-14.7%0.028%
8/8/2025Geode Capital Management LLC3,637,021$11.24M0.0%+2.7%1.899%
8/8/2025SBI Securities Co. Ltd.43,294$134K0.0%-45.1%0.023%
8/7/2025Los Angeles Capital Management LLC19,655$61K0.0%N/A0.010%
8/5/2025Bank of Montreal Can600,430$1.86M0.0%+3.3%0.313%
8/4/2025Wealth Management Associates Inc.104,920$324K0.1%+8.8%0.055%
7/29/2025VIRGINIA RETIREMENT SYSTEMS ET Al36,300$112K0.0%N/A0.019%
7/24/2025Aberdeen Group plc982,527$3.04M0.0%+110.2%0.513%
7/11/2025Assenagon Asset Management S.A.39,610$122K0.0%N/A0.021%
6/27/2025Goldman Sachs Group Inc.2,075,948$7.25M0.0%+290.3%1.084%
6/18/2025Voya Investment Management LLC41,523$145K0.0%-9.8%0.022%
5/29/2025Rhumbline Advisers200,757$701K0.0%+6.4%0.105%
5/28/2025Wealth Management Associates Inc.96,420$337K0.1%+58.0%0.050%
5/16/2025Woodline Partners LP2,655,738$9.27M0.1%+173.3%1.387%
5/16/2025Goldman Sachs Group Inc.2,075,948$7.25M0.0%+290.3%1.084%
5/16/2025Two Seas Capital LP9,465,956$33.04M1.0%+8.3%4.944%
5/16/2025Adage Capital Partners GP L.L.C.1,575,941$5.50M0.0%-4.5%0.823%
5/16/2025ADAR1 Capital Management LLC1,879,114$6.56M1.2%+20.9%0.981%
5/14/2025Rafferty Asset Management LLC82,864$289K0.0%-43.6%0.043%
5/14/2025MetLife Investment Management LLC88,887$310K0.0%+8.9%0.046%
5/14/2025EntryPoint Capital LLC18,730$65K0.0%N/A0.010%
5/13/2025Aberdeen Group plc467,383$1.63M0.0%N/A0.244%
5/12/2025Nuveen LLC313,307$1.09M0.0%N/A0.164%
5/12/2025Invesco Ltd.139,462$487K0.0%+99.7%0.073%
5/12/2025Mitsubishi UFJ Asset Management Co. Ltd.76,031$265K0.0%+9.1%0.040%
5/9/2025Deutsche Bank AG146,863$513K0.0%-14.5%0.077%
5/9/2025Vanguard Group Inc.8,953,823$31.25M0.0%-0.3%4.676%
5/8/2025XTX Topco Ltd72,412$253K0.0%+37.7%0.038%
5/7/2025Zurcher Kantonalbank Zurich Cantonalbank84,163$294K0.0%-6.1%0.044%
5/2/2025SBI Securities Co. Ltd.78,894$275K0.0%+9.2%0.041%
4/29/2025Bank of New York Mellon Corp348,797$1.22M0.0%-1.3%0.182%
4/28/2025Teacher Retirement System of Texas38,248$133K0.0%-9.2%0.020%
4/17/2025Cyndeo Wealth Partners LLC10,000$35K0.0%N/A0.005%
4/8/2025Rhumbline Advisers200,757$701K0.0%+6.4%0.105%
3/24/2025Wellington Management Group LLP513,302$1.68M0.0%+3.3%0.271%
2/18/2025Two Seas Capital LP8,740,956$28.58M2.2%+4.2%4.613%
2/17/2025UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC103,943$340K0.0%-46.9%0.055%
2/17/2025Whitefort Capital Management LP13,241,916$43.30M20.8%+2.9%6.988%
2/17/2025Woodline Partners LP971,628$3.18M0.0%+45.4%0.513%
2/17/2025Saba Capital Management L.P.887,993$2.90M0.1%+31.3%0.469%
2/17/2025Rafferty Asset Management LLC146,803$480K0.0%+27.6%0.077%
2/17/2025ProShare Advisors LLC50,121$164K0.0%+29.3%0.026%
2/17/2025Millennium Management LLC343,028$1.12M0.0%+36.7%0.181%
2/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.89,397$292K0.0%+10.2%0.047%
2/17/2025LMR Partners LLP158,249$517K0.0%-19.7%0.084%
2/17/2025Hudson Bay Capital Management LP1,112,500$3.64M0.0%+8.0%0.587%
2/17/2025Deutsche Bank AG171,766$562K0.0%+77.9%0.091%
2/17/2025Balyasny Asset Management L.P.41,690$136K0.0%N/A0.022%
2/17/2025Bank of America Corp DE361,304$1.18M0.0%+90.8%0.191%
2/17/2025BNP Paribas Financial Markets247,996$811K0.0%-19.1%0.131%
2/17/2025Ameriprise Financial Inc.18,917$62K0.0%N/A0.010%
2/14/2025Mercer Global Advisors Inc. ADV20,500$67K0.0%N/A0.011%
2/14/2025Northern Trust Corp1,330,683$4.35M0.0%+8.3%0.702%
2/14/2025Boothbay Fund Management LLC162,277$531K0.0%-73.5%0.086%
2/14/2025Susquehanna Fundamental Investments LLC202,541$662K0.0%N/A0.107%
2/14/2025Virtus ETF Advisers LLC19,970$65K0.0%-31.5%0.011%
2/14/2025Two Sigma Securities LLC19,475$64K0.0%N/A0.010%
2/14/2025Two Seas Capital LP8,740,956$28.58M2.5%+4.2%4.613%
2/14/2025Adage Capital Partners GP L.L.C.1,650,941$5.40M0.0%-43.1%0.871%
2/14/2025Price T Rowe Associates Inc. MD56,452$185K0.0%+18.1%0.030%
2/14/2025BlackBarn Capital Partners LP2,341,871$7.66M0.4%+13.1%1.236%
2/14/2025Hsbc Holdings PLC16,994$55K0.0%N/A0.009%
2/13/2025XTX Topco Ltd52,581$172K0.0%+75.2%0.028%
2/13/2025Barclays PLC298,253$975K0.0%+9.6%0.157%
2/13/2025Rockefeller Capital Management L.P.106,615$349K0.0%+69.2%0.056%
2/13/2025Quinn Opportunity Partners LLC404,879$1.32M0.1%+72.2%0.214%
2/13/2025Raymond James Financial Inc.10,504$34K0.0%N/A0.006%
(Data available from 1/1/2016 forward)

ABUS Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ABUS shares?

During the previous two years, 107 institutional investors and hedge funds held shares of Arbutus Biopharma. The most heavily invested institutionals were Whitefort Capital Management LP ($43.30M), Two Seas Capital LP ($32.27M), Vanguard Group Inc. ($31.25M), State Street Corp ($16.97M), Geode Capital Management LLC ($11.24M), Woodline Partners LP ($9.27M), and BlackBarn Capital Partners LP ($8.05M).Learn more on Arbutus Biopharma's institutional investors.

What percentage of Arbutus Biopharma's stock is owned by institutional investors?

43.79% of Arbutus Biopharma's stock is owned by institutional investors. Learn more on ABUS's institutional investor holdings.

Which institutional investors have been buying Arbutus Biopharma's stock?

Of the 91 institutional investors that purchased Arbutus Biopharma's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Goldman Sachs Group Inc. ($3.09M), Two Seas Capital LP ($2.41M), Woodline Partners LP ($1.99M), Rubric Capital Management LP ($1.68M), State Street Corp ($1.47M), Rangeley Capital LLC ($1.46M), and Hudson Bay Capital Management LP ($1.39M).

How much institutional buying is happening at Arbutus Biopharma?

Institutional investors have bought a total of 20,340,804 shares in the last 24 months. This purchase volume represents approximately $69.21M in transactions.

Which of Arbutus Biopharma's major shareholders have been selling company stock?

Of the 37 institutional investors that sold Arbutus Biopharma's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Adage Capital Partners GP L.L.C. ($1.33M), Hudson Bay Capital Management LP ($561.80K), ADAR1 Capital Management LLC ($534.52K), Rangeley Capital LLC ($484K), JPMorgan Chase & Co. ($452.55K), Boothbay Fund Management LLC ($450K), and BNP Paribas Financial Markets ($227.54K).

How much institutional selling is happening at Arbutus Biopharma?

Institutional investors have sold a total of 5,082,211 shares in the last 24 months. This volume of shares sold represents approximately $16.52M in transactions.



This page (NASDAQ:ABUS) was last updated on 9/10/2025 by MarketBeat.com Staff
From Our Partners